Clinical presentation does not affect acute mechanical performance of the Novolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography

INTRODUCTION: Initial trials of bioresorbable vascular scaffolds (BVS) have mostly excluded patients presenting with acute coronary syndrome (ACS). However, these patients might benefit from a BVS platform, in particular as they are often younger and have been less frequently treated than patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeder, Niklas F., Dörr, Oliver, Gaderer, Rosalina, Blachutzik, Florian, Achenbach, Stephan, Elsässer, Albrecht, Hamm, Christian, Nef, Holger M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596729/
https://www.ncbi.nlm.nih.gov/pubmed/34819963
http://dx.doi.org/10.5114/aic.2021.109239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596729/
https://www.ncbi.nlm.nih.gov/pubmed/34819963
http://dx.doi.org/10.5114/aic.2021.109239

Ejemplares similares